LIMERICK BIOPHARMA INC — Form D
LIMERICK BIOPHARMA INC of So. San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2010-12-20. The offering totals $3.6M, of which $3.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-12-20
- Form: D
- Accession: 0001358877-10-000003
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $3.6M
- Amount sold: $3.6M
- Investors: 13
- Date of first sale: 2010-11-03
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-152195
Issuer
- Name: LIMERICK BIOPHARMA INC
- CIK: 0001358877
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2004
- Address: 601 Gateway Boulevard, Suite 700, So. San Francisco, CA, 94080
- Phone: 650-742-0110
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Chad Waite | Director | SEATTLE, WA |
| Kristina Burow | Director | San Diego, CA |
| Corey Goodman | Director | Cambridge, MA |
| Stephen Dow | Director | Needham, MA |
| Steve Dow | Director | Seattle, WA |
| Scott Minick | Director | Sunnyvale, CA |
| Wendye Robbins | Director | SOUTH SAN FRANCISCO, CA |
| Wendye Robbins | Executive Officer | SOUTH SAN FRANCISCO, CA |
| Corey S Goodman | Director | Austin, TX |
| Ving Lee | Executive Officer | South San Francisco, CA |
| Asha Rajagopal | Executive Officer | South San Francisco, CA |
| Stephen M Dow | Director | So. San Francisco, CA |
Other filings by this issuer (6)
More